Financial giants have made a conspicuous bearish move on Johnson & Johnson. Our analysis of options history for Johnson & Johnson JNJ revealed 10 unusual trades.
Delving into the details, we found 20% of traders were bullish, while 80% showed bearish tendencies. Out of all the trades we spotted, 6 were puts, with a value of $272,347, and 4 were calls, valued at $162,746.
Predicted Price Range
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $130.0 to $180.0 for Johnson & Johnson over the recent three months.
Volume & Open Interest Trends
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Johnson & Johnson's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Johnson & Johnson's substantial trades, within a strike price spectrum from $130.0 to $180.0 over the preceding 30 days.
Johnson & Johnson Call and Put Volume: 30-Day Overview
Significant Options Trades Detected:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| JNJ | CALL | SWEEP | BEARISH | 02/21/25 | $5.8 | $5.55 | $5.55 | $145.00 | $55.5K | 140 | 102 |
| JNJ | PUT | SWEEP | BEARISH | 02/21/25 | $9.85 | $9.65 | $9.85 | $155.00 | $52.2K | 3.4K | 105 |
| JNJ | PUT | TRADE | BULLISH | 02/21/25 | $10.25 | $10.0 | $10.0 | $155.00 | $50.0K | 3.4K | 205 |
| JNJ | PUT | TRADE | BEARISH | 02/21/25 | $9.9 | $9.65 | $9.9 | $155.00 | $49.5K | 3.4K | 155 |
| JNJ | PUT | TRADE | BEARISH | 02/21/25 | $9.9 | $9.7 | $9.9 | $155.00 | $49.5K | 3.4K | 52 |
About Johnson & Johnson
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: pharmaceutical and medical devices. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. Geographically, just over half of total revenue is generated in the United States.
In light of the recent options history for Johnson & Johnson, it's now appropriate to focus on the company itself. We aim to explore its current performance.
Current Position of Johnson & Johnson
- Trading volume stands at 3,379,283, with JNJ's price down by -0.06%, positioned at $146.15.
- RSI indicators show the stock to be may be oversold.
- Earnings announcement expected in 40 days.
Professional Analyst Ratings for Johnson & Johnson
3 market experts have recently issued ratings for this stock, with a consensus target price of $177.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. Click here for access. * Maintaining their stance, an analyst from Citigroup continues to hold a Buy rating for Johnson & Johnson, targeting a price of $175. * In a cautious move, an analyst from B of A Securities downgraded its rating to Neutral, setting a price target of $166. * Reflecting concerns, an analyst from Wolfe Research lowers its rating to Outperform with a new price target of $190.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Johnson & Johnson options trades with real-time alerts from Benzinga Pro.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
